Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHNT.L Regulatory News (HNT)

  • There is currently no data for HNT

Trading Update

25 May 2017 07:00

RNS Number : 1609G
Huntsworth PLC
25 May 2017
 

 

Huntsworth

Trading update

 

Huntsworth plc, the healthcare communications and public relations group, is today issuing the following trading update for the four months to 30 April 2017.

 

· Group's full year results to be ahead of current consensus

· Strong trading at Huntsworth Health and Red

· Grayling trading in line with management expectations helped by UK agency returning to profit

 

Trading

 

The Group traded well through the first four months of the year, led again by strong growth at Huntsworth Health. On a like for like basis Huntsworth Health's revenues increased by over 10%, with good margin performance despite ongoing investment in talent and further diversification in two of the agencies. All of Huntsworth Health's main agencies grew in the period, led by the two largest - Evoke and Apothecom - which together account for circa 80% of divisional revenue.

 

Grayling's UK business returned to profitability in the period which means that, together with its European businesses, a large part of Grayling (representing circa 70% of annual divisional revenues) is now profitable. The US and META regions, however, remain challenging. Although we expect a decline in Grayling's like for like revenues this year, the division is trading in line with management's expectations.

 

Red has performed strongly in the period with revenues up by over 10%, with a number of new client wins. Some client churn is expected in the second half of the year which will dampen the overall annual growth rate.

 

Citigate Dewe Rogerson has experienced a mixed trading period with revenues down 2% on a like for like basis. Operations in the Netherlands, Singapore and Hong Kong have performed well, but slower transactional markets in the UK and mainland China have impacted overall revenue growth and profitability and will likely weigh on the business further during the year.

 

 

Financial Position

 

The Group remains in a strong financial position, operating well within its £70m facility. Net debt at 19 May 2017 was c. £31m, in line with management expectations.

 

 

Outlook

 

As a result of the stronger growth at Health and Red along with improved prospects at Grayling, we now expect the Group's full year results to be ahead of current consensus*.

 

The Group remains focused on driving operating profit by concentrating resources on its faster growing agencies and actively managing those underperforming ones. The Board is confident of continued progress through the remainder of 2017.

 

 

*Midpoint of consensus range for Headline PBT is £19.3m

 

 

 Enquiries

 

 

Citigate Dewe Rogerson

020 7638 9571

Georgia Colkin

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTPGUGPAUPMGQC
Date   Source Headline
12th May 20152:18 pmRNSDirector/PDMR Shareholding
5th May 201510:08 amRNSHolding(s) in Company
30th Apr 20154:26 pmRNSAnnual Financial Report
28th Apr 20153:57 pmRNSDirector/PDMR Shareholding
21st Apr 20153:10 pmRNSDirector/PDMR Shareholding
20th Apr 20151:07 pmRNSDirector/PDMR Shareholding
10th Apr 20157:00 amRNSAudited Preliminary Results
10th Mar 20154:02 pmRNSHuntsworth plc - Notice of Preliminary Results
12th Feb 201511:03 amRNSChief Executive Update
2nd Feb 20152:07 pmRNSTotal Voting Rights
16th Jan 20154:40 pmRNSSecond Price Monitoring Extn
16th Jan 20154:35 pmRNSPrice Monitoring Extension
22nd Dec 20142:54 pmRNSDirector/PDMR Shareholding
22nd Dec 201411:21 amRNSAppointment of new Chief Executive
19th Dec 20144:21 pmRNSDirector Declaration
19th Dec 201411:25 amRNSDirectorate Change
15th Dec 20144:35 pmRNSPrice Monitoring Extension
9th Dec 201410:06 amRNSHolding(s) in Company
5th Dec 20144:40 pmRNSSecond Price Monitoring Extn
5th Dec 20144:35 pmRNSPrice Monitoring Extension
1st Dec 201412:03 pmRNSBlocklisting Interim Review
20th Nov 20144:21 pmRNSDirectorate Change
3rd Nov 20149:31 amRNSTotal Voting Rights
28th Oct 20149:30 amRNSAdditional Listing
8th Oct 201410:09 amRNSDividend Declaration
7th Oct 20143:15 pmRNSDirectorate Change
1st Sep 20149:32 amRNSTotal Voting Rights
11th Aug 20144:56 pmRNSDirector/PDMR Shareholding - Replacement
11th Aug 20142:05 pmRNSDirector Declaration
11th Aug 20141:08 pmRNSDirector/PDMR Shareholding
11th Aug 20147:00 amRNSInterim results for the six months to 30 June 2014
6th Aug 20148:51 amRNSNotice of Results
1st Aug 201410:18 amRNSTotal Voting Rights
31st Jul 20143:08 pmRNSHolding(s) in Company
14th Jul 201410:10 amRNSDirector Update
14th Jul 20147:00 amRNSHuntsworth Trading Update
7th Jul 20149:36 amRNSHolding(s) in Company
3rd Jul 201412:34 pmRNSAdditional Listing
26th Jun 20149:16 amRNSNotification of Board Changes
25th Jun 20143:32 pmRNSHolding(s) in Company
24th Jun 201411:33 amRNSResult of AGM
4th Jun 20142:38 pmRNSScript Dividend Alternative
3rd Jun 201412:13 pmRNSBlocklisting Interim Review
27th May 20149:37 amRNSNotice of AGM
16th May 20142:59 pmRNSInterim Management Statement
2nd May 20141:51 pmRNSDirector/PDMR Shareholding
30th Apr 20143:31 pmRNSAnnual Financial Report
29th Apr 20147:00 amRNSAudited Preliminary Results 2013
28th Apr 20147:00 amRNSNotification of Board Changes
25th Apr 201410:51 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.